{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:03:13Z","timestamp":1790236993810,"version":"4.1.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Conventional respiratory vaccines protect through antigen-specific immunity, leaving broad gaps against antigenically diverse and emerging pathogens and inducing little protection at the airway surface itself. Trained immunity, the durable epigenetic and metabolic reprogramming of innate immune cells and their bone marrow progenitors, offers antigen-agnostic, heterologous protection and can be induced directly at the respiratory mucosa, providing a mechanistic rationale for a new class of prophylactic immunotherapies. Here we appraise this field from a clinical-translational, evidence-graded standpoint, integrating three interdependent axes. We first compare the principal inducer platforms (bacille Calmette-Gu\u00e9rin,\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -glucan and other pattern-recognition-receptor ligands, inactivated polybacterial preparations, and viral vectors) together with the intranasal, sublingual, and inhaled routes through which they deposit innate memory, showing that platform and route jointly govern the quality, location, and durability of protection. We then grade the clinical evidence population by population, which forms a gradient rather than a uniform endorsement: strongest for sublingual MV130 in childhood recurrent wheeze, moderate for bacille Calmette-Gu\u00e9rin in older adults and for MV130 in chronic obstructive pulmonary disease, and preliminary but promising in immunocompromised hosts. Throughout, we apply the protection-vs.-immunopathology balance as a critical lens, distinguishing host resistance from disease tolerance and highlighting the biomarkers and patient-selection strategies needed to steer benefit over harm. We conclude that trained immunity-based mucosal immunotherapy is best advanced not as a uniform promise but as a disciplined program aligning standardized interventions, mechanism-matched trial endpoints, and prospective biomarkers, positioning it as a credible complement to antigen-specific respiratory vaccines.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1950422","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:55:51Z","timestamp":1790236551000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trained immunity-based mucosal immunotherapies for preventing respiratory infections: a translational, evidence-graded appraisal of platforms, populations, and the protection\u2013immunopathology balance"],"prefix":"10.3389","volume":"13","author":[{"given":"Yanhong","family":"LYU","sequence":"first","affiliation":[{"name":"Department of Health Management Center, Qilu Hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019","volume":"400","author":"Ikuta","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-025-08910-6","article-title":"Nasal vaccines for respiratory infections","volume":"641","author":"Kiyono","year":"2025","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41385-022-00528-5","article-title":"Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling","volume":"15","author":"Zahalka","year":"2022","journal-title":"Mucosal Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"110184","DOI":"10.1016\/j.celrep.2021.110184","article-title":"Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections","volume":"38","author":"Brandi","year":"2022","journal-title":"Cell Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e155655","DOI":"10.1172\/jci.insight.155655","article-title":"Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans","volume":"7","author":"Jeyanathan","year":"2022","journal-title":"JCI Insight"},{"key":"B9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1164\/rccm.202003-0520OC","article-title":"Bacterial mucosal immunotherapy with Mv130 prevents recurrent wheezing in children: a randomized, double-blind, placebo-controlled clinical trial","volume":"204","author":"Nieto","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41590-024-02041-2","article-title":"\u0392-glucan reprograms neutrophils to promote disease tolerance against influenza a virus","volume":"26","author":"Khan","year":"2025","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O'Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.it.2025.02.012","article-title":"Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections","volume":"46","author":"Minute","year":"2025","journal-title":"Trends Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille calmette-guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","article-title":"Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity","volume":"24","author":"Arts","year":"2016","journal-title":"Cell Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41590-019-0568-x","article-title":"Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection","volume":"21","author":"Aegerter","year":"2020","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"114849","DOI":"10.1016\/j.celrep.2024.114849","article-title":"LPS-induced lung tissue-resident trained innate immunity provides differential protection against pneumococci and SARS-CoV-2","volume":"43","author":"Kang","year":"2024","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"108387","DOI":"10.1016\/j.celrep.2020.108387","article-title":"BCG vaccination induces long-term functional reprogramming of human neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","article-title":"Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity","volume":"175","author":"Yao","year":"2018","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2018.04.022","article-title":"Dietary fiber confers protection against flu by shaping Ly6c(\u2212) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism","volume":"48","author":"Trompette","year":"2018","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e106610","DOI":"10.7554\/eLife.106610","article-title":"Hematopoietic stem and progenitor cells as a reservoir for trained immunity","volume":"14","author":"Tran","year":"2025","journal-title":"Elife"},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/s41564-023-01503-x","article-title":"Intravenous bacille Calmette-Gu\u00e9rin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis","volume":"8","author":"Larson","year":"2023","journal-title":"Nat Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e17084","DOI":"10.15252\/emmm.202217084","article-title":"Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung","volume":"15","author":"Kang","year":"2023","journal-title":"EMBO Mol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107634","DOI":"10.1016\/j.celrep.2020.107634","article-title":"\u03b2-glucan induces protective trained immunity against Mycobacterium tuberculosis infection: a key role for IL-1","volume":"31","author":"Moorlag","year":"2020","journal-title":"Cell Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nut.2017.03.003","article-title":"Yeast-derived \u03b2-1,3\/1,6 glucan, upper respiratory tract infection and innate immunity in older adults","author":"Fuller","year":"2017","journal-title":"Nutrition"},{"key":"B33","doi-asserted-by":"publisher","first-page":"EVIDoa2100018","DOI":"10.1056\/EVIDoa2100018","article-title":"Sublingual MV140 for prevention of recurrent urinary tract infections","volume":"1","author":"Lorenzo-G\u00f3mez","year":"2022","journal-title":"NEJM Evid"},{"key":"B34","doi-asserted-by":"publisher","first-page":"612269","DOI":"10.3389\/fimmu.2020.612269","article-title":"A combination of polybacterial Mv140 and Candida albicans V132 as a potential novel trained immunity-based vaccine for genitourinary tract infections","volume":"11","author":"Martin-Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2637292","DOI":"10.1080\/22221751.2026.2637292","article-title":"An Rv1471-expressing chimpanzee adenovirus vaccine confers protection against tuberculosis by inducing alveolar macrophage trained immunity and polyfunctional T-cell responses","volume":"15","author":"Wang","year":"2026","journal-title":"Emerging Microbes Infect"},{"key":"B36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41590-023-01428-x","article-title":"Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs","volume":"24","author":"Wang","year":"2023","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/s1473-3099(23)00350-x","article-title":"Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-ncov after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial","volume":"23","author":"Li","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase III pivotal comparative clinical trial of intranasal (incovacc) and intramuscular COVID 19 vaccine (Covaxin(\u00ae))","volume":"8","author":"Singh","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41541-025-01307-6","article-title":"Adenoviral vector oropharyngeal spray immunization elicits mucosal immunity and protects against heterologous SARS-CoV-2 infection","volume":"10","author":"Koopman","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/s0140-6736(22)02644-7","article-title":"Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial","volume":"401","author":"Keech","year":"2023","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e69951","DOI":"10.7554\/eLife.69951","article-title":"Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice","volume":"10","author":"Gu","year":"2021","journal-title":"Elife"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/vaccines11101585","article-title":"Next generation mucosal vaccine strategy for respiratory pathogens","volume":"11","author":"Dotiwala","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nm1091","article-title":"Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity","volume":"10","author":"Moyron-Quiroz","year":"2004","journal-title":"Nat Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/vaccines12020172","article-title":"MV130 in the prevention of recurrent respiratory tract infections: a retrospective real-world study in children and adults","volume":"12","author":"Montalb\u00e1n-Hern\u00e1ndez","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing\u2009<\u20092500\u2005g: a randomized controlled trial","volume":"65","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","article-title":"The non-specific and sex-differential effects of vaccines","volume":"20","author":"Aaby","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"Br Med J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","article-title":"Randomized trial of BCG vaccine to protect against COVID-19 in health care workers","volume":"388","author":"Pittet","year":"2023","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1097\/ms9.0000000000002370","article-title":"Efficacy and outcomes of BCG re-vaccination in COVID-19: a systematic review, meta-analysis, and meta-regression of randomized controlled trials","volume":"86","author":"Jain","year":"2024","journal-title":"Ann Med Surg"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal bcg vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"De Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2600027","DOI":"10.1183\/13993003.00027-2026","article-title":"Prevention of copd exacerbations with a mucosal trained immunity-based vaccine (MV130): a randomised phase 3 trial","author":"Maestu","year":"2026","journal-title":"Eur Respir J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"611566","DOI":"10.3389\/fimmu.2020.611566","article-title":"Trained immunity-based vaccine in B cell hematological malignancies with recurrent infections: a new therapeutic approach","volume":"11","author":"Ochoa-Grull\u00f3n","year":"2021","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jaci.2024.09.011","article-title":"Mucosal trained immunity-based vaccines: cutting recurrent infections in autoimmune patients on immunosuppression","volume":"154","author":"Candelas","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1007\/s11357-025-01892-3","article-title":"Impaired early type I interferon responses to influenza virus infection in aged mice are associated with subsequent increased pulmonary inflammation","volume":"48","author":"Wu","year":"2026","journal-title":"GeroScience"},{"key":"B56","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/cells10030708","article-title":"Aging and interferons: impacts on inflammation and viral disease outcomes","volume":"10","author":"Feng","year":"2021","journal-title":"Cells"},{"key":"B57","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"Grade: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/vaccines13080825","article-title":"Immunogenicity, safety, and protective efficacy of mucosal vaccines against respiratory infectious diseases: a systematic review and meta-analysis","volume":"13","author":"Chen","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1016\/j.immuni.2024.08.018","article-title":"Antiviral innate immune memory in alveolar macrophages following sars-cov-2 infection ameliorates secondary influenza a virus disease","volume":"57","author":"Lercher","year":"2024","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity\u2014basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","article-title":"Innate immune training of granulopoiesis promotes anti-tumor activity","volume":"183","author":"Kalafati","year":"2020","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jaci.2024.09.009","article-title":"Trained immunity-based vaccines for infections and allergic diseases","volume":"154","author":"Mart\u00edn-Cruz","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3389\/fimmu.2018.00869","article-title":"Bacillus calmette-gu\u00e9rin-induced trained immunity is not protective for experimental influenza a\/anhui\/1\/2013 (H7N9) infection in mice","volume":"9","author":"de Bree","year":"2018","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41551-023-01050-0","article-title":"Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells","volume":"7","author":"Schrijver","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e147719","DOI":"10.1172\/jci147719","article-title":"Single-cell rna sequencing reveals induction of distinct trained-immunity programs in human monocytes","volume":"132","author":"Zhang","year":"2022","journal-title":"J Clin Invest"},{"key":"B68","doi-asserted-by":"publisher","first-page":"116939","DOI":"10.5501\/wjv.v15.i1.116939","article-title":"Next-generation mucosal vaccines for respiratory viruses: immunological correlates, platform design and clinical translation","volume":"15","author":"Younas","year":"2026","journal-title":"World J Virol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e163347","DOI":"10.1172\/jci.insight.163347","article-title":"Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells","volume":"7","author":"Yamaguchi","year":"2022","journal-title":"JCI Insight"},{"key":"B70","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/14760584.2024.2326094","article-title":"Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines","volume":"23","author":"Zhang","year":"2024","journal-title":"Expert Rev Vaccines"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1950422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:55:52Z","timestamp":1790236552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1950422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":70,"alternative-id":["10.3389\/fmed.2026.1950422"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1950422","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1950422"}}